Seborrheic Keratosis
Pipeline by Development Stage
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 17 trials with date data
Clinical Trials (17)
Total enrollment: 3,718 patients across 17 trials
An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses
Safety Study of A-101 Topical Solution for the Treatment of Common Warts
Study of A-101 Topical Solution for the Treatment of Common Warts
A Study of A-101 Topical Solution for the Treatment of Common Warts
An Open-Label Safety Study of A-101 Solution
A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic Keratosis
A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis.
A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis
Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic Keratosis
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts
A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra
A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis
A Study of A-101 Solution in Subjects With Common Warts.
Study of A-101 for the Treatment of Seborrheic Keratosis
Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis
Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.